These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8084370)

  • 1. [Electrophysiological studies in patients with familial myasthenia and health family members].
    Owczarek E; Emeryk-Szajewska B; Strugalska-Cynowska M
    Neurol Neurochir Pol; 1994; 28(3):419-24. PubMed ID: 8084370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
    Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
    Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of neuromuscular "jitter" under stimulation in the diagnosis of myasthenia gravis].
    Durand MC; Goulon-Goeau C; Gajdos P
    Neurophysiol Clin; 1997 Dec; 27(6):471-82. PubMed ID: 9488971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Facilitation phenomenon in electrophysiological diagnosis of myasthenia gravis].
    Emeryk B; Rowińska K; Michalska T
    Neurol Neurochir Pol; 1991; 25(2):156-62. PubMed ID: 1656295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up study of muscle function in children of mothers with myasthenia gravis during pregnancy.
    Ahlsten G; Lefvert AK; Osterman PO; Stålberg E; Säfwenberg J
    J Child Neurol; 1992 Jul; 7(3):264-9. PubMed ID: 1634748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The method of axonal stimulation (AS) for jitter evaluation in the diagnosis of neuromuscular transmission disorders].
    Michalska T; Rowińska K; Emeryk B
    Neurol Neurochir Pol; 1995; 29(3):333-42. PubMed ID: 7566408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial myasthenia gravis.
    Honeybourne D; Dyer PA; Mohr PD
    J Neurol Neurosurg Psychiatry; 1982 Sep; 45(9):854-6. PubMed ID: 7131024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic sensitivity of the laboratory tests in myasthenia gravis.
    Oh SJ; Kim DE; Kuruoglu R; Bradley RJ; Dwyer D
    Muscle Nerve; 1992 Jun; 15(6):720-4. PubMed ID: 1324429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
    Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
    J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis: familial occurrence. A study of 1100 myasthenia gravis patients.
    Szobor A
    Acta Med Hung; 1989; 46(1):13-21. PubMed ID: 2771581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor-alpha polymorphism and secretion in myasthenia gravis.
    Huang DR; Pirskanen R; Matell G; Lefvert AK
    J Neuroimmunol; 1999 Feb; 94(1-2):165-71. PubMed ID: 10376950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial myasthenia gravis: a study of three families.
    Chin D; Gubbay SS
    Clin Exp Neurol; 1985; 21():141-8. PubMed ID: 3843213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis and HLA antigens in American blacks and other races.
    Christiansen FT; Pollack MS; Garlepp MJ; Dawkins RL
    J Neuroimmunol; 1984 Dec; 7(2-3):121-9. PubMed ID: 6334696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Single fiber electromyography in the diagnosis of myasthenia gravis].
    Gómez-Fernández L; Vega-Treto H; Lestayo-Ofarril Z
    Rev Neurol; 2000 Apr 1-15; 30(7):609-13. PubMed ID: 10859737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The coexistence of myasthenia gravis and myotonic dystrophy in one family.
    Maytal J; Spiro AJ; Sinnar S; Moshe SL
    Neuropediatrics; 1987 Feb; 18(1):8-10. PubMed ID: 3561710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic factors in myasthenia gravis: a family study.
    Kerzin-Storrar L; Metcalfe RA; Dyer PA; Kowalska G; Ferguson I; Harris R
    Neurology; 1988 Jan; 38(1):38-42. PubMed ID: 3336461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the jitter phenomenon in myasthenic patients and their relatives.
    Hokkanen E; Emeryk-Szajewska B; Rowińska-Marcińska K
    J Neurol; 1978 Sep; 219(1):73-82. PubMed ID: 81286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular safety margin: genetical, immunological and electrophysiological determinants in relatives of myasthenic patients: a preliminary report.
    Pirkanen R; Bergström K; Hammarström L; Knutsson E; Lefvert AK; Matell G; Nilsson BY; Smith CI
    Ann N Y Acad Sci; 1981; 377():606-13. PubMed ID: 6951487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.